Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial.

doi:10.1016/j.amjcard.2009.12.049

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial.

The American journal of cardiology - 1 May 2010

Shiffman Dov, Sabatine Marc S, Louie Judy Z, Kirchgessner Todd G, Iakoubova Olga A, Campos Hannia, Devlin James J, Sacks Frank M

Abstract excerpt

A previous genetic analysis of the Cholesterol and Recurrent Events (CARE) trial found that carriers of the 719Arg allele of the kinesin family member 6 gene (KIF6) (rs20455), but not noncarriers, received significant event reduction from pravastatin therapy. However, that previous analysis of CA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol

Share to Double-Blind Method

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Kinesins

Share to Myocardial Infarction

Share to Pravastatin

Share to Secondary Prevention

Source

Open in PubMed

Identifiers

PMID: 20403483
DOI: 10.1016/j.amjcard.2009.12.049

Genes

KIF6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-20403483-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial.PMID 20403483Read ↗

Genetic variants in the KIF6 region and coronary event reduction from statin therapy.Semantic proximity Read ↗

Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.Semantic proximity Read ↗

<i>KIF6</i> Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER studySemantic proximity Read ↗

Impact of the 719Arg Variant of KIF6 and Major Cardiovascular Events on Patients who Received Statins: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies.Semantic proximity Read ↗

Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention.Semantic proximity Read ↗

A Common KIF6 Polymorphism Increases Vulnerability to Low-Density Lipoprotein Cholesterol: Two Meta-Analyses and a Meta-Regression AnalysisSemantic proximity Read ↗

KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly.Semantic proximity Read ↗

Impact of KIF6 Polymorphism rs20455 on Coronary Heart Disease Risk and Effectiveness of Statin Therapy in 100 Patients from Southern Iran.Semantic proximity Read ↗

Investigation of KIF6 Trp719Arg in a case-control study of coronary artery disease in Western Indians.Semantic proximity Read ↗

Meta-analyses of KIF6 Trp719Arg in coronary heart disease and statin therapeutic effect.Semantic proximity Read ↗

No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.